Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Monopar Therapeutics Inc. - Common Stock
(NQ:
MNPR
)
108.15
-0.94 (-0.86%)
Streaming Delayed Price
Updated: 10:08 AM EDT, Jul 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Monopar Therapeutics Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
January 20, 2023
It's the final day of trading this week and we're checking in on the biggest pre-market stock movers for Friday morning!
Via
InvestorPlace
Monopar Announces Successful Advancement of Camsirubicin Phase 1b Clinical Trial Past Fourth Cohort, Escalates Next to 650mg/m2
January 18, 2023
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
December 20, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tueday
↗
December 20, 2022
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
December 16, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
December 15, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
December 15, 2022
It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday!
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
December 12, 2022
Via
Benzinga
Monopar Announces Promising MNPR-202 Data from Ongoing National University of Singapore Collaboration
December 12, 2022
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
December 09, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
December 08, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
December 08, 2022
We're starting off the day with a look at the biggest pre-market stock movers that traders will want to watch on Thursday!
Via
InvestorPlace
Monopar Therapeutics Highlights Encouraging Data From Early-Stage Soft Tissue Cancer Study
↗
November 16, 2022
Via
Benzinga
Monopar Announces Encouraging Clinical Data from Ongoing Camsirubicin Phase 1b Trial
November 16, 2022
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
↗
November 11, 2022
Gainers
Via
Benzinga
Monopar Therapeutics Reports Third Quarter 2022 Financial Results and Recent Program Developments
November 10, 2022
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
↗
November 08, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
November 07, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
November 02, 2022
Gainers Monopar Therapeutics (NASDAQ:MNPR) shares increased by 53.0% to $4.09 during Wednesday's pre-market session. The company's market cap stands at $52.0 million.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
October 31, 2022
Gainers
Via
Benzinga
Monopar Announces Timeline of Upcoming Data Events for Validive, Camsirubicin, and MNPR-202
October 27, 2022
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
↗
November 01, 2022
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product...
Via
Benzinga
Monopar Announces Presentation Selected for 2022 American Society of Hematology (ASH) 64th Annual Meeting
October 19, 2022
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Announces Presentation Selected for 2022 Connective Tissue Oncology Society (CTOS) Annual Meeting
October 12, 2022
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Announces Completion of Phase 2b Enrollment and Commencement of Phase 3 Enrollment in its VOICE Trial for Severe Oral Mucositis
October 05, 2022
Interim Analysis Planned for Q1 2023
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar to Present at Roth Inaugural Healthcare Opportunities Conference
September 28, 2022
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Therapeutics: Q2 Earnings Insights
↗
August 11, 2022
Monopar Therapeutics (NASDAQ:MNPR) reported its Q2 earnings results on Thursday, August 11, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
June 03, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
May 26, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
↗
May 16, 2022
Welcome back and get ready for another busy week of trading as we start it off with the biggest pre-market stock movers for Monday!
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
